Scientific Program

8:30 –09:00  Gathering & Coffee


9:00- 9:15 Welcome and Introduction , Dr. Eran Halpern and Prof. Eytan Mor
 

09:15-11:15 Session 1- Medical issues

Chair: Dr. Amir Shlomai, Prof. Salomon Stemmer

09:15-09:55  Molecular signatures of liver tumors and the importance of liver biopsy in HCC.
Prof. Jessica zucman-rossi-French Institute of Health,France
 
 
09:55-10:35 Developments in loco-regional treatment of HCC   
Prof. Jens Rike-  Professor and Chairman, Department of Radiology University Hospital Munich

10:35-11:15 The role of m-TOR inhibitors for HCC in liver transplantation
Prof. Edward Geissler – Head of Experimental surgery, Dep. Of Surgery University Hospital Regensburg.

11:15- 11:45 Coffee Break


11:45-13:05 Session 2 –surgical issues 

Chair: Dr. Evyatar Nesher, Dr. Marius Braun

 
11:45-12:25 Liver Transplantation within Milan and Beyond; The role of down-staging
Dr. Myron Schwartz – Director of Hepatobiliary Surgery ,Mount Sinai Medical Center, NY.   
 
12:25-13:05- Approaches for Liver resection of HCC
Prof. Daniel Cherqui, Surgical Director of Liver Transplantation

Paul Brousse Hospital Villejuif, France


13:05-14:35 Session 3- Controversies in HCC treatment based on case studies 

Chair: Prof. Ziv Ben Ari, Dr. Riad Hadad

13:05-13:35 Recection vsTransplantation for treatment of HCC
Dr. Michal Cohen,Liver Institute ,Rabin Medical Center
13:35-14:05 Distinguishing malignant from pre-malignant lesions in cirrhotic patients
Dr. Yana Davidov , The Center of Liver Diseases , Sheba Medical Center
14:05-14:35  Resection & Transplantation  for HCC
Dr. Samir-Gazala,MD, Transplant Unit, Hadsssah Ein Kerem

14: 45 Lunch